The RT-qPCR experiment of gene expressions (H3, TP53, CDKN1A, BCL-2, and BAX) supported the antiproliferative action of diazaphenothiazines 34 and 35 and revealed the activation of the p53 pathway in cancer cells inducing the cell cycle arrest. The gene discussed is CDKN1A; the disease is cancer.